Potent achiral agonists of the growth hormone secretagogue (ghrelin) receptor. Part 2: Lead optimisation.
A series of small molecule orally bioavailable ghrelin receptor agonists have been identified through systematic optimisation of a high throughput screening hit.
Hlavní autoři: | Witherington, J, Abberley, L, Briggs, M, Collis, K, Dean, D, Gaiba, A, King, N, Kraus, H, Shuker, N, Steadman, J, Takle, A, Sanger, G, Wadsworth, G, Butler, S, McKay, F, Muir, A, Winborn, K, Heightman, T |
---|---|
Médium: | Journal article |
Jazyk: | English |
Vydáno: |
2008
|
Podobné jednotky
-
Potent achiral agonists of the ghrelin (growth hormone secretagogue) receptor. Part I: Lead identification.
Autor: Heightman, T, a další
Vydáno: (2007) -
Neuroprotective actions of ghrelin and growth hormone secretagogues
Autor: Laura M. Frago, a další
Vydáno: (2011-09-01) -
Mutational analysis of ghrelin and the growth hormone secretagogue receptor
Autor: Gueorguiev, M, a další
Vydáno: (2004) -
Rapid desensitisation of the GH secretagogue (ghrelin) receptor to hexarelin in vitro.
Autor: Orkin, R, a další
Vydáno: (2003) -
LEAP2 deletion in mice enhances ghrelin's actions as an orexigen and growth hormone secretagogue
Autor: Kripa Shankar, a další
Vydáno: (2021-11-01)